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In this work, we studied the localization and traf®c
of CD1a molecules in human epidermal Langerhans
cells and the ability of these cells to stimulate CD1a-
restricted T cell clones. We found that CD1a was
spontaneously internalized into freshly isolated
Langerhans cells, where it was rapidly distributed to
the early/sorting endosomes and then to the early/
recycling endosomes. In the latter compartments,
CD1a colocalized with Rab11, a small GTPase
known to be involved in the recycling of transmem-
brane proteins from early endosomes to the cell
surface. In the steady state, intracellular CD1a was
mainly located in Rab11+ recycling endosomal com-
partments. When endocytosis was blocked, intra-
cellular CD1a moved rapidly from the early/
recycling endosomes to the cell surface where it
accumulated. The resultant increase in the cell sur-
face expression of CD1a enhanced the capacity of
Langerhans cells to stimulate a CD1a-restricted T
cell clone. These ®ndings are consistent with a
dynamic exchange of CD1a between recycling com-
partments and the plasma membrane and suggest
that the antigen-presenting function of CD1a
depends on its traf®c through the early/recycling
endosomal pathway. Key words: dendritic cell/CD1a-
mediated T cell response/Rab11. J Invest Dermatol
116:401±408, 2001
L
angerhans cells are the representatives of the dendritic
cell lineage in the epidermis. Following antigen capture
in the skin, Langerhans cells migrate through the
afferent lymph to the T-cell-dependent areas of the
draining lymph nodes, where they present antigens to
naive T cells (Kripke et al, 1990; Moll et al, 1993). Langerhans cells
nevertheless differ at the ultrastructural level from other dendritic
cells through the presence of intracytoplasmic Birbeck granules and
from other epidermal cells by the fact that Langerhans cells are the
only cells of the epidermis to constitutively express major
histocompatibility complex (MHC) class II, Langerin, and CD1a
molecules at their surface (Valladeau et al, 2000).
CD1 molecules are a family of nonpolymorphic transmembrane
glycoproteins expressed in association with b2-microglobulin on
the surface of antigen-presenting cells such as B lymphocytes and
dendritic cells. Three closely related human CD1 proteins, called
CD1a, CD1b, and CD1c, are strongly expressed on dendritic cells,
and all three are involved in the speci®c responses of T cell
subpopulations having a CD4±CD8±, or CD8+ phenotype and
expressing ab or gd T cell receptors (TCR) (reviewed by Maher
and Kronenberg, 1997). These T cells react either directly with the
CD1 molecules, in the absence of any external antigen, or with
CD1 molecules presenting microbial lipid and glycolipid antigens
(Beckman et al, 1994; 1996; Sieling et al, 1995; Stenger et al, 1997;
Rosat et al, 1998; Burdin and Kronenberg, 1999). The intracellular
traf®c of CD1 molecules and the mechanisms by which they load
and present antigens in professional antigen-presenting cells like
Langerhans cells are nevertheless still poorly de®ned. In Langerhans
cells, which express almost exclusively the CD1a isoform at the cell
surface (Fithian et al, 1981; Caux et al, 1992), this molecule was
shown to be internalized (Hanau et al, 1987; Ray et al, 1989). The
cytoplasmic tail of CD1a does not contain any identi®ed endosomal
targeting signal, however, and its intracellular localization as well as
its intracellular traf®c are still poorly understood.
In this study, we investigated the localization and traf®c of CD1a
in freshly isolated human epidermal Langerhans cells and the ability
of these cells to stimulate CD1a-restricted T cell clones. The
majority of intracellular CD1a molecules were found in the early/
recycling endosomes, where they colocalized with Rab11, a small
GTPase known to regulate the dynamic exchange between
pericentriolar recycling endosomes and the plasma membrane
(Ullrich et al, 1996; Ren et al, 1998; Casanova et al, 1999; Cox et al,
2000). Consistent with these ®ndings, we could demonstrate the
existence of a dynamic traf®c of CD1a between the early/sorting
endosomes, the early/recycling compartments, and the plasma
membrane. Inhibition of endocytosis led to a redistribution of
internal CD1a to the cell surface, which enhanced the capacity of
Langerhans cells to stimulate a CD1a-restricted T cell clone. Thus,
our ®ndings suggest that the passage of CD1a through the early/
recycling endosomal compartments is essential for Langerhans cells
to ef®ciently perform CD1a-restricted antigen presentation.
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MATERIALS AND METHODS
Antibodies, cultures, and reagents Mouse monoclonal antibodies
(MoAbs) were as follows: L243 (IgG2a, anti-DRab dimers, Becton
Dickinson Immunocytochemistry Systems, San Jose, CA), ¯uorescein
isothiocyanate (FITC) conjugated H1149 (IgG1, anti-CD1a, Pharmingen,
San Diego, CA), CTR433 (recognizing a cis/medial Golgi antigen, kindly
provided by Dr. M. Bornens, Institut Curie, Paris) (Jasmin et al, 1989),
H5C6 (IgG1, anti-CD63, kindly provided by Dr. FrancËois Lanza, EFS-
Alsace, Strasbourg), and H4B4 (IgG1, anti-Lamp-2 (CD107b),
Pharmingen). Rabbit anti-EEA1 antiserum (Simonsen et al, 1998) was a
generous gift of Dr. Harald Steinmark, EMBL, Heidelberg. A polyclonal
rabbit anti-Rab11 antibody was raised against full-length recombinant
Rab11 expressed in Escherichia coli and af®nity puri®ed essentially as
described previously (Martinez et al, 1994). L243, H5C6, and puri®ed anti-
Rab11 rabbit IgGs were directly coupled to Cyanin 3 using a CY3-link kit
(Amersham France, Les Ullis, France) according to the manufacturer's
instructions. Mouse FITC-IgG1 (Pharmingen) was used as an isotype
control in cytometric analyses. Texas-Red-coupled donkey antimouse IgG
F(ab¢)2 fragments (Jackson ImmunoResearch, West Grove, PA) were
employed for indirect immuno¯uorescence staining. The MoAbs BL4
(IgG2a, anti-CD4, Immunotech, Marseille, France), B9.2 (IgG3, anti-
CD8a, Immunotech), and Immu 510 (IgG1, anti-Pan g/d, Immunotech)
were employed for the negative selection of double-negative T cell lines.
Rabbit complement-MA (Cedarlane Laboratories, Hornby, Ontario,
Canada) was used for the cytotoxic elimination of T cells expressing
CD4, CD8, or TCR-g/d. Sheep antimouse IgG-coupled magnetic beads
(Dynabeads M-450) and magnetic beads directly conjugated with a mouse
anti-CD14 MoAb (RM052) (Dynabeads M-450 CD14) were purchased
from Dynal (Oslo, Norway). In electron microscopy experiments, the
mouse MoAb PdV5.2 (IgG1, antihuman MHC class II DR, DP, DQ)
(Koning et al, 1985) was used directly conjugated to 10 nm gold particles, as
previously described (Van Praag et al, 1994). Gold-conjugated Fab
fragments of the anti-CD1a MoAb BL6 (Immunotech) were obtained
from Aurion (Wageningen, The Netherlands). A mouse anti-CD1a MoAb
(clone 66-II-C7, IgG2a, Monosan, Sanbio, The Netherlands) was revealed
by indirect immunogold staining with rabbit antimouse IgG (Dakopatts)
followed by protein A-colloidal gold. Isotype matched irrelevant antibodies
served as controls.
Cultures were established in RPMI 1640 medium containing
Glutamax-I, 10% heat-inactivated fetal bovine serum (FBS), 1% sodium
pyruvate, and 50 U per ml penicillin and streptomycin (all from Life
Technologies, Paisley, U.K., complete medium). Recombinant human
granulocyte-macrophage colony stimulating factor (GM-CSF) was a
generous gift of Novartis (Rueil Malmaison, France), recombinant human
interleukin-4 (IL-4) was obtained from PeproTech (Rocky Hill, NJ), and
recombinant human IL-2 was provided by Chiron France (Suresnes,
France). Mycobacterium tuberculosis (avirulent strain H37RA) was obtained as
a dessicated heat-killed powder (Difco Laboratories, Detroit, MI). Bacterial
antigen extracts were prepared by probe sonication of approximately 50 mg
of lyophilized bacteria in 4 ml phosphate-buffered saline (PBS), and were
clari®ed by ultracentrifugation at 100,000 3 g to remove insoluble material.
FLUOS was provided by Boehringer (Meylan, France) and latrunculin A
(L-12370) by Molecular Probes (Eugene, OR). Cytochalasin D (C 8273),
Brefeldin A (B 7651), and all other chemicals were from Sigma (St. Louis,
MO).
Cells Epidermal cell suspensions were prepared as previously described
(Hanau et al, 1987). These suspensions were enriched in Langerhans cells by
gradient centrifugation on Lymphoprep (Flobio, Courbevoie, France) and
the Langerhans cell yield was typically 30%±50% of the ®nal cell
population. Dendritic cells expressing CD1a, CD1b, and CD1c were
derived from elutriated human blood monocytes. Monocytes were isolated
by continuous ¯ow centrifugation leukapheresis and counter¯ow
centrifugation elutriation (Faradji et al, 1994) and were cultured in
complete medium supplemented with 50 ng per ml recombinant human
GM-CSF and 40 ng per ml recombinant human IL-4. Differentiated
dendritic cells were used at day 6 or 7 and the differentiation of monocytes
was checked by ¯ow cytometric analysis of surface markers (Saudrais et al,
1998).
CD1a-restricted CD4± CD8± ab T cell clones were obtained as
described by Beckman et al (1996). Brie¯y, lymphocyte populations were
isolated by continuous ¯ow centrifugation leukapheresis and counter¯ow
centrifugation elutriation. To obtain CD4± CD8± ab T cells, lymphocytes
were treated with the MoAb BL4 (anti-CD4), B9.2 (anti-CD8a), and
Immu 510 (anti-Pan g/d), washed, and incubated with rabbit complement-
MA. The remaining viable cells were resuspended in a solution containing
a mixture of the same three MoAb, washed, and incubated with Dynabeads
M-450 and Dynabeads M-450 CD14. After magnetic separation, the CD4±
CD8± ab T cells [75% pure by ¯uorescence-activated cell sorter (FACS)
analysis] were cultured with equal numbers of irradiated CD1+ autologous
monocyte-derived dendritic cells in the presence of My tuberculosis
sonicate (1:200 dilution). The culture medium was RPMI 1640
supplemented with Glutamax-I, 10 mM HEPES, and 10% FBS. After
2 wk, viable cells were recovered and restimulated with heterologous
irradiated CD1+ dendritic cells and My sonicate, and antigen-reactive T
cells were expanded by addition of 100 U per ml recombinant human IL-2
on day 3 after stimulation. These CD4± CD8± ab T cell lines were
maintained in continuous growth by restimulation every 14 d with My
sonicate and heterologous CD1+ dendritic cells and feeding every 3±4 d
with fresh culture medium containing 100 U per ml human IL-2. T cell
clones were derived by limiting dilution culture. T cells were seeded at an
average density of 0.5 cells per well in 0.2 ml cultures in 96-well round-
bottomed microtiter plates (Costar, Cambridge, MA), together with
1.5 3 105 irradiated (5000 rad) heterologous peripheral blood mononuclear
cells and 0.3 3 105 irradiated (7500 rad) heterologous Epstein-Barr virus
transformed B lymphoblastoid cells as a feeder layer. The medium was
RPMI 1640 containing 10% FBS, 100 U per ml recombinant human IL-2,
and 0.5 mg per ml PHA-L (L-4144, Sigma).
Cytotoxicity assays The CD1a restriction of the T cell clones was
tested in cytolytic assays using mock transfected C1R cells (ATCC,
CRL1993, Rockville, MD) and C1R cells stably transfected with CD1a,
CD1b, or CD1c as target cells. Brie¯y, mock or CD1 transfected C1R cells
were incubated overnight in the presence or absence of My tuberculosis
sonicate (1:200 dilution), and 5 3 106 cells were labeled with 100 mCi 51Cr
(Na251CrO4, Amersham France) for 90 min at 37°C with intermittent
agitation. After extensive washing, the labeled cells (5 3 103 per well) were
seeded in 96-well V-bottomed microtiter plates (Costar). Effector cells
were added in 100 ml per well of culture medium at an effector:target ratio
of 20:1 in triplicate wells. The plates were centrifuged at 200 3 g for 2 min
and incubated for 4 h at 37°C, after which the cell-free supernatants were
collected and their radioactivity was measured in an automated gamma
counter. Of 20 T cell clones tested, only one (Fig 1) lyzed exclusively C1R
cells expressing CD1a and not mock transfectants or C1R cells expressing
CD1b or CD1c. Clone 114 appeared to recognize CD1a directly,
independent of the presence of exogenous bacterial antigens. Flow
cytometric analyses showed that the T cell clone 114 expressed TCR-ab
and was CD4± CD8± (data not shown).
Flow cytometry Epidermal cells enriched in freshly isolated Langerhans
cells were washed once in RPMI 1640 supplemented with 10% FBS and
resuspended in the same medium. The cells were then either immediately
cooled to 4°C or incubated for 30 or 60 min at 37°C in the presence or
absence of Brefeldin A (10 mg per ml), latrunculin A (12.5 mg per ml),
cytochalasin D (10 mg per ml), or Brefeldin A and cytochalasin D (10 mg
per ml each), and then cooled to 4°C. Langerhans cells were labeled by
incubating the epidermal cells with FITC-conjugated anti-CD1a at 4°C for
30 min. After washing, the cells were ®xed and analyzed with a FACScan
cytometer (Becton Dickinson). Isotype controls were stained and analyzed
simultaneously.
Figure 1. T cell clone 114 lyzed CD1a-transfected C1R cells. C1R
cells stably transfected with vector alone (mock) or with CD1a, CD1b, or
CD1c were used as target cells in cytolytic assays with the T cell clone 114.
The percentage speci®c lysis of each transfectant is shown for an effector to
target ratio of 20:1. Open bars show lysis of target cultured in medium alone
(no antigen) and solid bars show lysis of target cells cultured overnight with
My antigen (1:200 dilution of Mycobacterium tuberculosis sonicate).
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Immuno¯uorescence staining and confocal microscopy Immuno-
¯uorescence microscopy of ®xed permeabilized Langerhans cells was carried
out as previously described (Saudrais et al, 1998). Double staining with FITC-
anti-CD1a was performed as follows. After permeabilization with 0.05%
saponin in PBS containing 0.2% bovine serum albumin, the adherent cells
were incubatedwith speci®cMoAb (CTR433 recognizing a cis/medialGolgi
antigen or anti-Lamp2), washed three times, and stained with Texas-Red-
conjugated donkey antimouse IgG. The cells were washed again, ®xed for
5 min in 3% paraformaldehyde, quenched for 10 min, and incubated with
FITC-conjugated anti-CD1a for 60 min, after which the coverslips were
mounted in Mowiol. Double staining was also carried out using FITC-anti-
CD1a and CY3-L243 (anti-HLA DRab) or CY3-H5C6 (anti-CD63). In
other experiments, the cells were treated with either latrunculin A (12.5 mg
per ml) or cytochalasin D (10 mg per ml) in the presence or absence of BFA
(10 mg per ml) for various times at 37°C, before ®xation, permeabilization,
and double staining with FITC-anti-CD1a and CY3-anti-Rab11. Confocal
laser scanning microscopy and immuno¯uorescence quanti®cation were
performed as described elsewhere (Salamero et al, 1996) using a Leica TCS4D
confocal microscope (Leica Microsystems, Heidelberg, Germany).
MoAb internalization Freshly isolated Langerhans cells were incubated
for 1 h at 4°C with FITC-conjugated anti-CD1a (5 mg per ml) in RPMI
1640 supplemented with 10% FBS. After several washes in cold PBS, the
cells were left to internalize the bound MoAb for various times at 37°C or
20°C and allowed to adhere to glass coverslips precoated with poly L-
lysine. The cells were then ®xed, permeabilized, and double stained with
CY3-L243 (3 mg per ml), CY3-anti-Rab11 (5 mg per ml), or rabbit
anti-EEA1 antiserum (1:2000 dilution), which was further revealed
with Texas-Red-conjugated donkey antirabbit IgG F(ab¢)2 (Jackson
ImmunoResearch). Similar experiments were performed using cells
pretreated with cytochalasin D (10 mg per ml) or latrunculin A (12.5 mg
per ml).
Immunoelectron microscopy Freshly isolated epidermal cells were
®xed in 1% paraformaldehyde and 0.1% glutaraldehyde and processed for
immunoelectron microscopy according to Mommaas et al (1992). Ultrathin
cryosections were successively incubated with anti-CD1a (1:100), rabbit
antimouse IgG, and protein A 5 nm colloidal gold, followed by 10 nm
gold-conjugated PdV5.2 (1:1000). The sections were embedded in
methylcellulose, stained with uranyl acetate, and examined under a
Philips 410 electron microscope. In some experiments, epidermal cells
were cooled to 4°C for 10 min, incubated for 60 min at 4°C with 10 nm
gold-labeled Fab fragments of BL6 (anti-CD1a, ®nal dilution 1:100), and
®xed at 4°C for examination on Epon sections (Saudrais et al, 1998).
Proliferation assays Freshly isolated Langerhans cells were treated or
not for 1 h at 37°C with cytochalasin D (10 mg per ml), ®xed in 0.01%
glutaraldehyde for 1 min at 4°C to prevent any further intracellular traf®c,
and washed several times in culture medium. Proliferation assays were
carried out in a ®nal volume of 200 ml in the wells of 96-well U-bottomed
microtiter plates (Costar), using 2.5 3 104 T cells and a variable number of
®xed Langerhans cells. The culture medium was RPMI 1640 containing
Glutamax-I and 10% heat-inactivated FBS, and all cultures were set up in
triplicate. Controls included responder T cells alone. Cultures were
harvested on day 3 with a Skatron cell harvester after an 18 h pulse with
1 mCi [3H]-thymidine, and [3H] incorporation was determined in a
Betaplate counter (LKB Wallac, EG&G Instruments, Evry, France). Small
aliquots containing Langerhans cells were taken from all conditions and
processed as above for FACS analyses.
RESULTS
Intracellular localization of CD1a in freshly isolated
Langerhans cells The intracellular fate of CD1a was
characterized in freshly isolated human Langerhans cells, in which
CD1a predominates on the cell surface. We ®rst determined the
steady-state cellular distribution of CD1a using double
immuno¯uorescence staining on ®xed and permeabilized
Langerhans cells. As shown by confocal microscopy (Fig 2),
CD1a was present not only on the cell surface but also in an
intracellular pool. These internal CD1a molecules did not
colocalize with lysosomal markers (Lamp-2, Fig 2C) or the Golgi
apparatus (CTR433, Fig 2D) and seemed to only partially
colocalize with MHC class II molecules (CY3-L243, Fig 2A) and
CD63 (CY3-H5C6, Fig 2B). Immunoelectron microscopy of
ultrathin cryosections (Fig 3C-E) revealed CD1a essentially on the
Figure 2. Steady-state distribution of CD1a
molecules in freshly isolated Langerhans
cells. Immuno¯uorescence staining was performed
on cells ®xed in PFA and permeabilized with
saponin as described in Materials and Methods. The
cells were double stained with FITC-conjugated
anti-CD1a and (A) CY3-L243 (anti-HLA-
DRab), (B) CY3-H5C6 (anti-CD63), (C) anti-
Lamp-2, or (D) CTR433 (recognizing a cis/
medial Golgi antigen), and analyzed by confocal
microscopy. In (C) and (D), the cells were incub-
ated ®rst with CTR433 or anti-Lamp-2, then
with Texas-Red-conjugated donkey antimouse
IgG, and ®nally with FITC-conjugated anti-
CD1a. Images are representative of three separate
experiments. Scale bars: 5 mm.
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cell surface (Fig 3C) and in early endosomes (Fig 3C, D). CD1a
was also present in Birbeck granules (Fig 3C) and sparingly in some
MHC class II positive compartments (MIIC) (Fig 3E). The most
striking observation was the spontaneous presence of CD1a in
numerous coated structures appended to the Langerhans cell surface
(Fig 3A-C), suggesting a dynamic constitutive internalization of
this molecule.
Constitutive endocytosis of CD1a in freshly isolated
Langerhans cells The spontaneous internalization of CD1a
was visualized in freshly isolated Langerhans cells by binding of an
anti-CD1a MoAb directly coupled to FITC for 1 h at 4°C (Fig 4A,
T0) and further incubation at 37°C for various times. Within
15 min, some of the MoAb previously bound to the cell surface was
found in an intracellular pool distinct from the MIIC (Fig 4A,
T15). Using an acid stripping assay and FACS analysis, we
calculated that, in different freshly isolated Langerhans cells, 24%-
36% of the MoAb had internalized after 15 min chase at 37°C (data
not shown). After 45 min at 37°C, CD1a was still detected at the
cell surface, whereas the internalized CD1a only partially
colocalized with MHC class II (Fig 4A, T45). When Langerhans
cells were chased for longer times (T120), the ¯uorescent signal of
the internalized anti-CD1a MoAb decreased, compared with early
time points (T15), whereas the plasma membrane staining remained
strong. Although this could have resulted from a redistribution of
the CD1a-MoAb complexes between intracellular compartments
and the plasma membrane, degradation of the MoAb following its
partial internalization could not be excluded. Confocal images
taken with ®xed acquisition parameters (Salamero et al, 1996)
showed no signi®cant decrease in the total anti-CD1a ¯uorescence
intensity during CD1a internalization (up to 45 min, Fig 4B),
which supported the hypothesis of a rapid internalization/recycling
of plasma membrane CD1a in freshly isolated Langerhans cells. If
CD1a undergoes a recycling process, inhibition of endocytosis
under conditions where recycling to the plasma membrane is not
affected should allow the internal pool to redistribute to the plasma
membrane. Cytochalasin D and latrunculin A, known to,
respectively, depolymerize and sequester F-actin ®laments, have
been shown to block the initial steps of endocytosis without
affecting the recycling pathway (Durrbach et al, 1996; Lamaze et al,
1997). In this study, cytochalasin D and latrunculin A were equally
ef®cient in blocking the internalization of a MoAb bound to CD1a
at the surface of freshly isolated Langerhans cells (Fig 5A-C). When
the cells were incubated with the drugs for various times at 37°C
(Fig 5D), FACS analyses revealed a rapid increase in cell surface
CD1a, which reached a plateau after only 1 h of incubation with
either cytochalasin D or latrunculin A. This cell surface
accumulation did not involve newly synthesized CD1a
molecules, as treatment of freshly isolated Langerhans cells with
BFA did not affect the upregulation of CD1a. Moreover, the
presence of BFA alone for up to 2 h did not modify the rate of
expression of CD1a at the plasma membrane of Langerhans cells.
These data are consistent with the continuous recycling of
preexisting CD1a molecules from an internal pool to the cell
surface, where drugs affecting F-actin block their endocytosis.
CD1a recycles from early endosomes to the plasma
membrane of freshly isolated Langerhans cells Among
Rab proteins, which are known to modulate certain steps of
membrane traf®c, Rab11 has been shown to regulate the recycling
of transferrin receptors. This cytosolic protein associates with the
membrane of the pericentriolar early/recycling endosomes (Ullrich
et al, 1996; Ren et al, 1998), allowing their distinction from the
early/sorting endosomes identi®ed by Rab5 (Bucci et al, 1992) or
its effector EEA1 (Christoforidis et al, 1999; McBride et al, 1999).
Therefore, to better characterize the intracellular distribution of
CD1a, permeabilized freshly isolated Langerhans cells were double
immunolabeled for CD1a and Rab11, Rab5, or EEA1. As seen on
optical sections (Fig 6), steady-state internal CD1a colocalized
strongly with Rab11 in early/recycling endosomes (Fig 6A) and
Figure 3. Electron microscopy revealed the spontaneous presence
of CD1a in coated pits and its preferential accumulation in the early
endosomal network. (A), (B) Freshly isolated Langerhans cells were
incubated for 60 min at 4°C with gold-labeled Fab fragments of the anti-
CD1a MoAb BL6. On Epon sections, gold particles were found at the
Langerhans cell surface and in coated pits. One gold-labeled coated pit is
visible (arrowheads) in (A) and at higher magni®cation in (B). (C)-(E)
Ultrathin cryosections of freshly isolated Langerhans cells labeled for CD1a
(5 nm gold) and MHC class II molecules (10 nm gold) revealed CD1a at the
Langerhans cell surface (C), in early endosomes (star) (C, D) and in Birbeck
granules (arrow) (C). CD1a molecules were present at low levels in some
compartments enriched in MHC class II molecules (MIIC) (E). Note the
presence, in the upper right-hand corner of (E), of numerous vesicles
strongly labeled by the anti-CD1a MoAb, which could be involved in
recycling of CD1a to the cell surface. Scale bars: 0.1 mm.
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poorly with Rab5 (not shown) or its effector EEA1 in early/sorting
endosomes (Fig 6B) (Simonsen et al, 1998). When the
internalization of a cell-surface-bound anti-CD1a MoAb was
delayed, however, by leaving the cells for 20 min at 20°C rather
than 37°C, CD1a was frequently seen to colocalize with markers of
the early/sorting endosomes (Fig 6C). In contrast, internalization
for 20 min at 37°C was suf®cient to allow CD1a to move from the
EEA1 positive sorting compartments (Fig 6D) and enabled the
anti-CD1a MoAb to reach the pericentriolar recycling
compartments labeled with Rab11 (Fig 6D, insert). When freshly
isolated Langerhans cells were incubated with cytochalasin D
(Fig 6E-H) or latrunculin A (data not shown), CD1a molecules
originating from the intracellular Rab11 positive compartments
were detected at the plasma membrane within 1 h. This
cytochalasin-D-induced upregulation of CD1a at the surface of
Langerhans cells enhanced the capacity of Langerhans cells to
stimulate the CD1a-restricted T cell clone 114. Indeed, as shown in
Fig 7, proliferation of the CD1a-restricted T cell clone 114 was
increased by addition of CD1a+ Langerhans cells and further
enhanced by their pretreatment with cytochalasin D, which
induced an accumulation of CD1a at the Langerhans cell surface.
Together with our ¯ow cytometric observation of a rapid increase
in CD1a at the cell surface, under the same experimental
conditions, this demonstrated that CD1a constitutively recycles to
the plasma membrane of freshly isolated Langerhans cells, mainly
from the Rab11 positive early/recycling endosomes, and suggests
that these recycling CD1a molecules are involved in the stimulation
of speci®c T cells.
DISCUSSION
The aims of this study were to determine the distribution and the
intracellular fate of CD1a in freshly isolated Langerhans cells. Our
knowledge in these domains indeed remains fragmentary. Pre-
viously, we showed that gold-conjugated anti-CD1a MoAb
internalized at the surface of freshly isolated Langerhans cells and
gained access to the early endosomal network and Birbeck granules
(Hanau et al, 1987). In this study, using morphologic approaches
and double immunolabeling for CD1a and markers of different
internal membranes, we identi®ed the intracellular compartments
of Langerhans cells where CD1a molecules spontaneously accu-
mulate. Despite infrequent colocalization of CD1a and MHC class
II molecules in intracellular structures, CD1a positive organelles all
belonged to the early endosomal pathway including clathrin-coated
pits and vesicles. Spontaneous accumulation of CD1a in Birbeck
granules was also observed, suggesting that these Langerhans-cell-
speci®c structures are related to the early endosomes. Intracellular
CD1a molecules in fact predominantly colocalized with endo-
genous Rab11 in the pericentriolar recycling endosomes. When
internalized from the cell surface, CD1a ®rst moved to early/
sorting endosomes and then accumulated in early/recycling
Figure 4. Internalization of CD1a in freshly isolated Langerhans
cells. (A) Freshly isolated Langerhans cells were incubated with FITC-
conjugated anti-CD1a for 1 h at 4°C, washed, and incubated at 37°C for
the indicated times in minutes (T0, T15, T45, T120). After rapid ®xation
in PFA and permeabilization with saponin, the cells were double stained for
MHC class II with CY3-L243 (anti-HLA-DRab) and the samples were
analyzed by confocal microscopy (scale bars: 5 mm). (B) Confocal series
(eight consecutive optical sections, each separated by 0.5 mm) of at least 50
different cells at each time point were taken with ®xed acquisition
parameters. The total anti-CD1a ¯uorescence intensity of reconstituted
stacks of these series was then quanti®ed by image analysis and expressed as
the percentage (6 SE) of the total ¯uorescence intensity at T0.
Figure 5. Blockade of CD1a endocytosis in freshly isolated
Langerhans cells. (A) Freshly isolated Langerhans cells were incubated
with an FITC-conjugated anti-CD1a MoAb for 1 h at 4°C, washed, and
incubated at 37°C for 20 min without drug treatment. Alternatively, freshly
isolated Langerhans cells were pretreated with cytochalasin D (10 mg
per ml) (B) or latrunculin A (12.5 mg per ml) (C) for 30 min at 37°C,
washed, and incubated at 37°C for 20 min with FITC-anti-CD1a in the
continuous presence of the drugs. The cells were then ®xed and analyzed
by confocal microscopy. (D) Freshly isolated Langerhans cells were
incubated with cytochalasin D (10 mg per ml), latrunculin A (12.5 mg
per ml), BFA (10 mg per ml), or both cytochalasin D and BFA for various
times at 37°C and CD1a surface expression was analyzed by FACS scan.
Results shown are representative of three separate experiments.
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endosomes. These ®ndings strongly suggest that in freshly isolated
Langerhans cells a dynamic exchange of CD1a molecules occurs
between early endosomal compartments and the plasma membrane.
They are in agreement with previous work published by Sugita et al
(1999), who showed that, in HeLa cells transfected with CD1a and
CD1b, the transient expression of a GTPase mutant of ARF6
(ARF6-T27N), a protein known to regulate vesicle recycling
(D'Souza-Schorey et al, 1998), induced an accumulation of CD1a
in vesicles labeled with ARF6-T27N, suggesting that CD1a might
recycle through ARF6-regulated vesicles.
What drives the constitutive endocytosis of CD1a in freshly
isolated Langerhans cells remains unclear. The frequent occurrence
of CD1a in clathrin-coated pits of the plasma membrane indicates
that delivery through clathrin-coated vesicles may be the
predominant CD1a internalization pathway in these cells. What
part of the CD1a molecule signals its recruitment into clathrin-
coated pits, however, is unknown. Other members of the CD1
family like CD1b and CD1c are structurally very similar and
contain a tyrosine-based endosomal/lysosomal targeting signal
YXXé in their cytoplasmic tail. This motif is predicted to induce
a ``tight turn'' con®guration (Bansal and Gierasch, 1991; Eberle et al,
1991), which associates with adaptor complexes to allow clathrin-
mediated internalization or late endosomal targeting (Ohno et al,
1995, 1996; Boll et al, 1996; Honing et al, 1996). CD1a, in contrast,
contains no known endocytic signals in its cytoplasmic tail. CD1
molecules nevertheless associate with a number of other molecules
(reviewed by Calabi and Bradbury, 1991), and CD1a has been
shown to associate noncovalently with CD1b, CD1c, and MHC
class I heavy chains (Amiot et al, 1988) and covalently with CD8 at
the surface of thymocytes (Ledbetter et al, 1985; Snow et al, 1985).
Thus, endocytosis of CD1a could be mediated by a still unde®ned
companion protein. Alternatively, mechanisms other than peptide
targeting might account for the recruitment of CD1a into clathrin-
coated structures. As an example, it is known that binding of
bacterial Shiga toxin to the glycolipid Gb3 directs this toxin into
clathrin-coated pits for entry into cells (Sandvig et al, 1989).The
most important information of this study was derived from the
effects on CD1a distribution and intracellular traf®c induced by
treatment of Langerhans cells with drugs known to speci®cally
block endocytosis without affecting the recycling pathway
(Durrbach et al, 1996; Lamaze et al, 1997). Inhibition of endocytosis
led to disappearance of CD1a from the pericentriolar Rab11
positive recycling compartments and its concomitant upregulation
at the cell surface, which was independent of the synthesis of new
CD1a molecules. A morphologic analysis of CD1a distribution
Figure 6. Internal CD1a molecules were mainly present in the
recycling endosomal compartments of freshly isolated Langerhans
cells. (A), (B) Permeabilized freshly isolated Langerhans cells were double
immunolabeled for CD1a (green staining, A and B) and Rab11 (red
staining, A) or EEA1 (red staining, B). (C), (D) An FITC-conjugated anti-
CD1a MoAb, previously bound to the surface of freshly isolated
Langerhans cells at 4°C, was internalized for 20 min at 20°C (C) or 37°C
(D). The cells were then ®xed, permeabilized, and stained for EEA1 (red
staining, C and D) or Rab11 (red staining, insert in D). (E)-(H) Freshly
isolated Langerhans cells were incubated with cytochalasin D for 0, 15, 30,
or 60 min at 37°C. The cells were then ®xed, permeabilized, and double
labeled for CD1a (green staining) and Rab11 (red staining). Images are
representative of three separate experiments. Scale bars: 10 mm.
Figure 7. Increasing CD1a cell surface expression in freshly isolated
Langerhans cells enhances their capacity to stimulate a CD1a-
restricted T cell clone. Freshly isolated Langerhans cells were treated or
not for 1 h at 37°C with cytochalasin D (10 mg per ml) and ®xed in 0.01%
glutaraldehyde. Proliferation assays were carried out using 2.5 3 104 T cells
from the CD1a-restricted T cell clone 114 and a variable number of ®xed
Langerhans cells. All cultures were set up in triplicate.
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during treatment of Langerhans cells with cytochalasin D or
latrunculin A indicated that CD1a recycled from the pericentriolar
Rab11 positive compartments directly to the cell surface without
traveling through the more peripheral Rab5/EEA1 positive early/
sorting compartments. This is the ®rst direct demonstration that
CD1a constitutively recycles between the plasma membrane and
the pericentriolar early/recycling compartments.
Rab11 regulates the late recycling of transferrin receptors in a
number of cell types (Ullrich et al, 1996). It was also recently
suggested that Rab11 might regulate important functions of
another antigen-presenting cell, the macrophage, by participating
in the rapid mobilization of endosomal membranes to the cell
surface, which leads to the enhancement of microbe phagocytosis
(Cox et al, 2000). Internalization of lipid antigens in an antigen-
presenting cell is necessary for CD1a-mediated antigen presentation
(Sugita et al, 1999). It is thus conceivable that in freshly isolated
Langerhans cells lipid antigens encounter CD1a in early endosomes
during the recycling of these molecules and are returned to the cell
surface in association with CD1a through a Rab11-regulated
pathway. As an indirect argument in favor of the importance of
CD1a recycling for antigen presentation, we showed in this study
that treatment of freshly isolated Langerhans cells with drugs
blocking endocytosis also resulted in an increased capacity of the
cells to stimulate a CD1a-restricted T cell clone. Such apparently
autoreactive T cells might recognize self lipid antigens bound to the
CD1a molecules (Moody et al, 1999). Thus, CD1a could
supplement the immune defense machinery of human Langerhans
cells by presenting lipid antigens that might have preferential access
to the recycling endosomal pathway (Mukherjee et al, 1999). One
may speculate that in the case of epidermal Langerhans cells, which
express high levels of CD1a but virtually no CD1b at the cell
surface, this could correspond to the ®rst immunologic barrier
allowing the recognition of bacterial lipids by T cells. Strikingly,
this process would progressively cease as the Langerhans cells
maturate. Thus, maturation of freshly isolated Langerhans cells in
the presence of tumor necrosis factor-a leads to a reduction in their
CD1a expression, in contrast to MHC class II molecules. Whether
lipid presentation is then mediated by other CD1 molecules, for
instance the CD1c molecules initially present in MHC class II
containing compartments in freshly isolated Langerhans cells (data
not shown), remains to be investigated.
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